Espen Ø. Kvale

831 total citations
15 papers, 709 citations indexed

About

Espen Ø. Kvale is a scholar working on Immunology, Physiology and Biochemistry. According to data from OpenAlex, Espen Ø. Kvale has authored 15 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Physiology and 4 papers in Biochemistry. Recurrent topics in Espen Ø. Kvale's work include T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Espen Ø. Kvale is often cited by papers focused on T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Espen Ø. Kvale collaborates with scholars based in Norway, United Kingdom and Croatia. Espen Ø. Kvale's co-authors include Prabal K. Chatterjee, Christoph Thiemermann, Nimesh S. A. Patel, Hélder Mota‐Filipe, Keith N. Stewart, Paul A. Brown, Salvatore Cuzzocrea, Trygve Holmøy, Frode Vartdal and Frode L. Jahnsen and has published in prestigious journals such as Blood, Kidney International and Journal of Allergy and Clinical Immunology.

In The Last Decade

Espen Ø. Kvale

15 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Espen Ø. Kvale Norway 11 194 190 174 166 127 15 709
Khaled Khazim Israel 13 144 0.7× 195 1.0× 195 1.1× 66 0.4× 312 2.5× 16 878
Eleonora Cravero Italy 10 123 0.6× 83 0.4× 166 1.0× 78 0.5× 305 2.4× 13 703
Xiaogang Du China 16 88 0.5× 122 0.6× 204 1.2× 71 0.4× 245 1.9× 44 791
Sayaka Arakawa Japan 11 218 1.1× 96 0.5× 148 0.9× 39 0.2× 183 1.4× 36 731
Felicia Y. T. Yap Australia 12 139 0.7× 92 0.5× 135 0.8× 71 0.4× 209 1.6× 15 1.0k
Dhruv K. Singh United Kingdom 11 119 0.6× 49 0.3× 287 1.6× 92 0.6× 202 1.6× 19 798
Fabio Gianiorio Italy 9 156 0.8× 109 0.6× 211 1.2× 48 0.3× 220 1.7× 10 706
Alice M. Sheridan United States 14 70 0.4× 64 0.3× 302 1.7× 133 0.8× 342 2.7× 23 917
Lionel C. Clément United States 11 152 0.8× 107 0.6× 402 2.3× 88 0.5× 343 2.7× 17 1.1k
Hermann Joseph Gröne Germany 8 88 0.5× 58 0.3× 257 1.5× 61 0.4× 323 2.5× 8 863

Countries citing papers authored by Espen Ø. Kvale

Since Specialization
Citations

This map shows the geographic impact of Espen Ø. Kvale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Espen Ø. Kvale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Espen Ø. Kvale more than expected).

Fields of papers citing papers by Espen Ø. Kvale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Espen Ø. Kvale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Espen Ø. Kvale. The network helps show where Espen Ø. Kvale may publish in the future.

Co-authorship network of co-authors of Espen Ø. Kvale

This figure shows the co-authorship network connecting the top 25 collaborators of Espen Ø. Kvale. A scholar is included among the top collaborators of Espen Ø. Kvale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Espen Ø. Kvale. Espen Ø. Kvale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Skrindo, I., Lóránt Farkas, Espen Ø. Kvale, Finn–Eirik Johansen, & Frode L. Jahnsen. (2008). Depletion of CD4+CD25+CD127lo regulatory T cells does not increase allergen‐driven T cell activation. Clinical & Experimental Allergy. 38(11). 1752–1759. 8 indexed citations
2.
Vartdal, Frode, Agnete B. Fredriksen, K. M. Thompson, et al.. (2007). T Cells from Multiple Sclerosis Patients Recognize Multiple Epitopes on Self‐IgG. Scandinavian Journal of Immunology. 66(4). 393–401. 14 indexed citations
3.
Villa, Irène, Espen Ø. Kvale, Fridtjof Lund‐Johansen, & Johanna Olweus. (2007). Assay for monitoring in vitro selective depletion strategies in allogeneic stem cell transplantation. Cytotherapy. 9(6). 600–610. 1 indexed citations
4.
Holmøy, Trygve, Per M. Roos, & Espen Ø. Kvale. (2006). ALS: Cytokine profile in cerebrospinal fluid T‐cell clones. Amyotrophic Lateral Sclerosis. 7(3). 183–186. 13 indexed citations
5.
Farkas, Lóránt, Espen Ø. Kvale, Fridtjof Lund‐Johansen, & Frode L. Jahnsen. (2006). Plasmacytoid Dendritic Cells Induce a Distinct Cytokine Pattern in Virus‐Specific CD4+ Memory T Cells that is Modulated by CpG Oligodeoxynucleotides. Scandinavian Journal of Immunology. 64(4). 404–411. 5 indexed citations
6.
Kvale, Espen Ø., Yngvar Fløisand, Fridtjof Lund‐Johansen, et al.. (2006). Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells. Blood. 109(8). 3369–3376. 19 indexed citations
7.
Kvale, Espen Ø., Jakob Dalgaard, Fridtjof Lund‐Johansen, et al.. (2005). CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood. 107(5). 2022–2029. 47 indexed citations
8.
Chatterjee, Prabal K., Nimesh S. A. Patel, Espen Ø. Kvale, et al.. (2004). EUK-134 Reduces Renal Dysfunction and Injury Caused by Oxidative and Nitrosative Stress of the Kidney. American Journal of Nephrology. 24(2). 165–177. 31 indexed citations
9.
Farkas, Lóránt, Espen Ø. Kvale, Finn–Eirik Johansen, Frode L. Jahnsen, & Fridtjof Lund‐Johansen. (2004). Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: Modulation by CpG oligodeoxynucleotides. Journal of Allergy and Clinical Immunology. 114(2). 436–443. 63 indexed citations
10.
Holmøy, Trygve, Espen Ø. Kvale, & Frode Vartdal. (2004). Cerebrospinal fluid CD4+T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein. Journal of NeuroVirology. 10(5). 278–283. 73 indexed citations
11.
Chatterjee, Prabal K., Nimesh S. A. Patel, Espen Ø. Kvale, et al.. (2003). The tyrosine kinase inhibitor tyrphostin AG126 reduces renal ischemia/reperfusion injury in the rat. Kidney International. 64(5). 1605–1619. 17 indexed citations
12.
Thiemermann, Christoph, Nimesh S. A. Patel, Espen Ø. Kvale, et al.. (2003). High Density Lipoprotein (HDL) Reduces Renal Ischemia/Reperfusion Injury. Journal of the American Society of Nephrology. 14(7). 1833–1843. 68 indexed citations
13.
Chatterjee, Prabal K., Nimesh S. A. Patel, Ahila Sivarajah, et al.. (2003). GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney International. 63(3). 853–865. 129 indexed citations
14.
Chatterjee, Prabal K., Espen Ø. Kvale, Nimesh S. A. Patel, & Christoph Thiemermann. (2003). GW274150 inhibits nitric oxide production by primary cultures of rat proximal tubular cells.. PubMed. 9(10). BR357–62. 8 indexed citations
15.
Chatterjee, Prabal K., Nimesh S. A. Patel, Espen Ø. Kvale, et al.. (2002). Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney International. 61(3). 862–871. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026